A prognostic model to predict the individual disease-specific survival (DSS) rates of non-metastatic esophageal cancer (nMEC) patients after preoperative radiotherapy (pRT) has not been established. In the current study, we aimed to establish a survival nomogram for nMEC patients after pRT.
https://www.dovepress.com/nomogram-predicts-survival-benefit-for-non-metastatic-esophageal-cance-peer-reviewed-article-CMAR
Nomogram predicts survival benefit for non-metastatic esophageal cancer patients who underwent preoperative radiotherapy